Korea Bio-Gen Co.Ltd Cash Flow Conversion Efficiency
Korea Bio-Gen Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, Korea Bio-Gen Co.Ltd (318000) has a cash flow conversion efficiency ratio of 0.032x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.51 Billion ≈ $1.02 Million USD) by net assets (₩46.98 Billion ≈ $31.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Korea Bio-Gen Co.Ltd (2017–2025)
Cash flow conversion efficiency of Korea Bio-Gen Co.Ltd from 2017 to 2025. This chart illustrates how Korea Bio-Gen Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 318000 share price today for real-time trading data and today's change.
Korea Bio-Gen Co.Ltd Cash Flow Conversion Ratio Explained
Korea Bio-Gen Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Korea Bio-Gen Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Korea Bio-Gen Co.Ltd ranked by their cash flow conversion efficiency. Also see Korea Bio-Gen Co.Ltd (318000) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quantum Software SA
WAR:QNT
|
0.102x |
|
Ihlas Gazetecilik AS
IS:IHGZT
|
-0.003x |
|
Niocan Inc
V:NIO
|
-0.039x |
|
Waja Konsortium Bhd
KLSE:0102
|
-0.028x |
|
Nuriplan Co. Ltd
KQ:069140
|
0.043x |
|
TRC Construction Public Company Limited
BK:TRC
|
0.069x |
|
Daesung Microbiological Labs. Co. Ltd
KQ:036480
|
0.027x |
|
Sejoong Co. Ltd
KQ:039310
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Korea Bio-Gen Co.Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Korea Bio-Gen Co.Ltd from 2017 to 2025. Review Korea Bio-Gen Co.Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩46.93 Billion ≈ $31.80 Million |
₩7.34 Billion ≈ $4.97 Million |
0.156x | +63.74% |
| 2024-12-31 | ₩44.91 Billion ≈ $30.44 Million |
₩4.29 Billion ≈ $2.91 Million |
0.096x | -57.57% |
| 2023-12-31 | ₩42.05 Billion ≈ $28.50 Million |
₩9.47 Billion ≈ $6.42 Million |
0.225x | +371.25% |
| 2022-12-31 | ₩34.95 Billion ≈ $23.68 Million |
₩1.67 Billion ≈ $1.13 Million |
0.048x | -51.19% |
| 2021-12-31 | ₩31.61 Billion ≈ $21.42 Million |
₩3.09 Billion ≈ $2.10 Million |
0.098x | +6.83% |
| 2020-12-31 | ₩28.16 Billion ≈ $19.09 Million |
₩2.58 Billion ≈ $1.75 Million |
0.092x | -22.91% |
| 2019-12-31 | ₩25.69 Billion ≈ $17.41 Million |
₩3.05 Billion ≈ $2.07 Million |
0.119x | -34.28% |
| 2018-12-31 | ₩10.97 Billion ≈ $7.44 Million |
₩1.98 Billion ≈ $1.34 Million |
0.181x | +16.60% |
| 2017-12-31 | ₩8.93 Billion ≈ $6.05 Million |
₩1.38 Billion ≈ $938.31K |
0.155x | -- |
About Korea Bio-Gen Co.Ltd
KBG Corp. produces and supplies a range of fine chemicals in South Korea and internationally. The company offers silicone chemicals, such as functional organosilanes, functional silicone polymers, silicone resins and intermediates, silicone pressure sensitive adhesives, and silicone materials for electronics; specialty chemicals, including polymerization inhibitors; and food additives, as well as… Read more